Iloprost in Preventing Lung Cancer in Former Smokers
NCT02237183
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
NIH
Sponsor class
Conditions
Lung Carcinoma
Interventions
DRUG:
Iloprost
OTHER:
Placebo Administration
OTHER:
Quality-of-Life Assessment
OTHER:
Questionnaire Administration
Sponsor
National Cancer Institute (NCI)